Brief: Noxopharm Appoints Gisela Mautner As Chief Executive Officer
05/01/2022 01:09
Jan 5 (Reuters) - Noxopharm Ltd NOX.AX :
* APPOINTMENT OF GISELA MAUTNER AS CHIEF EXECUTIVE OFFICER
* GISELA MAUTNER WILL SERVE ON BOARD AS EXECUTIVE MANAGING
DIRECTOR
Source text for Eikon: ID:nASX7vp4hq
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer